Last reviewed · How we verify
viscosupplementation
At a glance
| Generic name | viscosupplementation |
|---|---|
| Sponsor | Istituto Ortopedico Rizzoli |
| Modality | Biologic |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- "Intra-articular Hyaluronic Acid Injection for Accelerating Functional Recovery After Knee Arthroscopy" (NA)
- Orthobiological Therapies in Musculoskeletal Disorders (EARLY_PHASE1)
- Safety of Use and Efficacy of Pandora for Patients Suffering From Gonarthrosis (PANDORA2) (NA)
- Clinical Investigation of Sensovisc (NA)
- Clinical Investigation of Sensovisc Sterile Sodium Hyaluronate Gel (NA)
- Effectiveness and Safety of Intra-articular SEMICAL GEL-B CROSS Therapy in Knee Osteoarthritis (SEM-ART1) (NA)
- Hyaluronic Acid in Overuse Knee Pain (PHASE2, PHASE3)
- Efficacy and Safety of Sinovial®HL Single Injection in the Knee Osteoarthritis
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- viscosupplementation CI brief — competitive landscape report
- viscosupplementation updates RSS · CI watch RSS
- Istituto Ortopedico Rizzoli portfolio CI